# Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension

> **NCT02279160** · PHASE2 · COMPLETED · sponsor: **United Therapeutics** · enrollment: 61 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** APD811
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02279160
- **Lead sponsor:** United Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2020-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02279160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02279160, "Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02279160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*